Literature DB >> 25277974

Heme oxygenase-1 promoter polymorphisms and neonatal jaundice.

Michael Kaplan1, Paul Renbaum, Cathy Hammerman, Hendrik J Vreman, Ronald J Wong, David K Stevenson.   

Abstract

BACKGROUND: Heme oxygenase (HO) is the initial, rate-limiting enzyme in the conversion of heme to bilirubin. Dinucleotide (GT)n repeat length in the promoter region of the encoding gene modulates transcription: shorter alleles, in contrast with longer allele counterparts, are associated with greater gene expression and should result in increased heme catabolism.
OBJECTIVE: We compared the rates of heme catabolism and plasma total bilirubin (TB) between HO-1 promoter genotypes of varying (GT)n repeat lengths in glucose-6-phosphate dehydrogenase (G6PD)-normal and -deficient neonates.
METHODS: HO-1 promoter length was determined from genomic DNA from previous studies by size discrimination of fluorescently-labeled PCR products with capillary electrophoresis. Sizing was confirmed by sequencing homozygote samples. Alleles were categorized as: short (≤24 GT repeats), medium (25-33 GT repeats), and long (≥34 GT repeats). Previously determined values for blood carboxyhemoglobin, corrected for inspired carbon monoxide (COHbc), and TB were used to determine the rate of heme catabolism and 3rd day TB values for each HO-1 promoter length genotype, respectively. G6PD Mediterranean was determined by PCR analysis.
RESULTS: Neither COHbc nor TB values were significantly different between various HO-1 promoter genotypes for either G6PD-normal or -deficient neonates.
CONCLUSIONS: In the steady state, HO-1 promoter genotypes, based on the length of (GT)n repeats, do not modulate heme catabolism or 3rd day TB values in either G6PD-normal or -deficient neonates.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25277974     DOI: 10.1159/000365744

Source DB:  PubMed          Journal:  Neonatology        ISSN: 1661-7800            Impact factor:   4.035


  6 in total

Review 1.  Heme oxygenase-1 promoter polymorphisms: do they modulate neonatal hyperbilirubinemia?

Authors:  M Kaplan; R J Wong; D K Stevenson
Journal:  J Perinatol       Date:  2017-02-16       Impact factor: 2.521

2.  Multiple Genetic Modifiers of Bilirubin Metabolism Involvement in Significant Neonatal Hyperbilirubinemia in Patients of Chinese Descent.

Authors:  Hui Yang; Qian Wang; Lei Zheng; Min Lin; Xiang-bin Zheng; Fen Lin; Li-Ye Yang
Journal:  PLoS One       Date:  2015-07-06       Impact factor: 3.240

3.  Risk assessment of gene variants for neonatal hyperbilirubinemia in Taiwan.

Authors:  Yi-Hao Weng; Ya-Wen Chiu; Shao-Wen Cheng; Chun-Yuh Yang
Journal:  BMC Pediatr       Date:  2016-08-24       Impact factor: 2.125

Review 4.  Two Faces of Heme Catabolic Pathway in Newborns: A Potential Role of Bilirubin and Carbon Monoxide in Neonatal Inflammatory Diseases.

Authors:  Wiktoria Osiak; Sławomir Wątroba; Lucyna Kapka-Skrzypczak; Jacek Kurzepa
Journal:  Oxid Med Cell Longev       Date:  2020-08-18       Impact factor: 6.543

5.  Association of heme oxygenase-1 single nucleotide polymorphisms with susceptibility to tuberculosis in Chinese Han population.

Authors:  Jingcan Wu; Shouquan Wu; Qianqian Liu; Yu Wang; Guiyi Ji; Andrew J Sandford; Jian-Qing He
Journal:  J Clin Lab Anal       Date:  2020-03-06       Impact factor: 2.352

Review 6.  The Role of Heme Oxygenase-1 Promoter Polymorphisms in Perinatal Disease.

Authors:  Ruka Nakasone; Mariko Ashina; Shinya Abe; Kenji Tanimura; Hans Van Rostenberghe; Kazumichi Fujioka
Journal:  Int J Environ Res Public Health       Date:  2021-03-29       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.